Chapter 3. The Role of Ethnicity in Managing Cardiovascular Patients

  1. Dan Roden MD Professor Director Assistant Vice-Chancellor
  1. Raymond Hreiche PharmD, PhD,
  2. Veronique Michaud BPharm, PhD and
  3. Jacques Turgeon PhD

Published Online: 27 APR 2009

DOI: 10.1002/9781444311785.ch3

Cardiovascular Genetics and Genomics

Cardiovascular Genetics and Genomics

How to Cite

Hreiche, R., Michaud, V. and Turgeon, J. (2009) The Role of Ethnicity in Managing Cardiovascular Patients, in Cardiovascular Genetics and Genomics (ed D. Roden), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444311785.ch3

Editor Information

  1. Oates Institute for Experimental Therapeutics, Personalized Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA

Author Information

  1. Faculty of Pharmacy, Université de Montréal, Montréal, Québec, Canada

Publication History

  1. Published Online: 27 APR 2009
  2. Published Print: 17 APR 2009

Book Series:

  1. The AHA Clinical Series

Book Series Editors:

  1. Elliott Antman

ISBN Information

Print ISBN: 9781405175401

Online ISBN: 9781444311785



  • cardiovascular disease (CVD);
  • warfarin treatment failure;
  • ethanol consumption;
  • treatment adherence;
  • polymorphisms;
  • drug metabolism;
  • drug targets;
  • anticoagulant therapy;
  • genomic revolution


This chapter contains sections titled:

  • Introduction

  • Environmental and cultural factors in treatment response

  • Role of genetic factors in treatment efficacy and toxicity

  • Towards an individualized therapy for better management of cardiovascular patients from ethnic minorities?

  • References